Name Net reduced
positions
Reduced positions Increased positions Return since
31 Mar ‘16
926
5 42 37 1.42%
927
5 19 14 79.8%
928
5 196 191 152%
RWK icon
929
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.11B
5 12 7 177%
930
5 20 15 77.8%
931
5 10 5 602%
932
5 10 5 69.7%
933
5 12 7 46.1%
934
5 15 10 17.1%
935
5 35 30 60.7%
PLX icon
936
Protalix BioTherapeutics
PLX
$162M
5 10 5 76%
937
4 19 15 137%
938
4 35 31 409%
939
4 5 1 7.5%
940
4 25 21 1.01%
941
4 12 8 65.1%
942
4 208 204 255%
943
4 4 0 108%
944
4 20 16 336%
945
4 10 6 1,271%
946
4 15 11 25.4%
947
4 4 0 502%
948
4 11 7 20.3%
949
4 12 8 75.3%
950
4 9 5 16.3%